**Specifications Table**TableSubject area*Biology*More specific subject area*Molecular genetics, Public health genomics*Type of data*Figure, Table*How data was acquired*Survey, Blood sample collection, MassARRAY platform (Sequenom Inc., San Diego, CA, USA) with iPLEX Gold chemistry*Data format*Analyzed*Experimental factors*Genomic DNA from peripheral blood was isolated*Experimental features*Genotyping method of SNPs was based on MALDI-TOF (Matrix Assisted Laser Desorption-Ionisation-Time Of Flight) analysis, performed on MassARRAY Platform.*Data source location*Debrecen, Hungary, Latitude:* 47.544062, 21° 38′ 25′′ E *& Longitude:* 21.64283, 47° 32′ 33′′ NData accessibility*Data are presented in this article; DNA sample and raw data are available for further analyses in collaborative studies*

**Value of the data**•Several studies describe the health status of the Roma, which constitutes the largest ethnic minority in Europe however studies focusing on their genetic predisposition to common chronic diseases are scarce.•Genetic background of atherosclerosis among Roma as well as the general Hungarian population can be studied separately or in international cohort.•Genetic risk score assessment can be further utilized to compare susceptibility to reduced HDL-C level among different population groups.

1. Data {#s0005}
=======

Distribution of SNPs related to HDL-C level were analysed in the Hungarian Roma and general populations and weighted Genetic Risk Scores were defined and used to categorize the population into quintiles.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Subjects {#s0015}
-------------

Study involved subjects of samples investigated during recent cross sectional surveys [@bib2], [@bib3]. The Roma sample is representative to the Roma population living settlements in North-East Hungary in terms of age and sex and includes 646 individuals (Roma). The "General" sample consisting of 1542 individuals representative for the Hungarian general population in terms of geographic, age and sex distributions.

2.2. DNA extraction {#s0020}
-------------------

DNA was isolated using a MagNA Pure LC system (Roche Diagnostics, Basel, Switzerland) with a MagNA Pure LC DNA Isolation Kit--Large Volume according to the manufacturer\'s instructions. Extracted DNA was eluted in 200 µl MagNA Pure LC DNA Isolation Kit-Large Volume elution buffer.

2.3. SNP selection {#s0025}
------------------

A systematic literature review on the PubMed, HuGE Navigator and Ensembl databases was conducted to identify SNPs most strongly associated with HDL-C metabolism ([Table 1](#t0005){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"}). The selection process of the SNPs is demonstrated in detail in our research article [@bib1].Fig. 1Haplotype block organization of SNPs related to high-density lipoprotein cholesterol level on the LD maps for the Hungarian general (A) and Roma (B) populations. Linkage analyses were performed separately in the study populations. According to the LD map generated by Haploview, there are four haplotype blocks (outlined in a bold black line) consisting of variants that are in high LD. The blocks were formed by the SNPs of the *CETP*, *LIPC* and *GALNT2* genes. The numbers above the map show the rs numbers of SNPs. The colour scheme is a standard Haploview colour scheme (white *D*′\<1 and LOD\<2, shades of pink/red: *D*′\<1 and LOD≥2, and bright red *D*′=1 and LOD≥2). Numbers in squares are *D*′ values.Fig. 1Table 1List of the SNPs which were involved in the research.Table 1Nearest GeneGene (short)SNP (rs number)ChromosomeApolipoprotein BAPOBrs6932ATP-binding cassette transporter ABCA1ABCA1rs41492689Cholesteryl ester transfer proteinCETPrs153262416Cholesteryl ester transfer proteinCETPrs588216Cholesteryl ester transfer proteinCETPrs70827216Cholesteryl ester transfer proteinCETPrs749989216Cholesteryl ester transfer proteinCETPrs998941916Endothelial lipaseLIPGrs200081318Endothelial lipaseLIPGrs493988318Hepatic lipaseLIPCrs1046801715Hepatic lipaseLIPCrs107783415Hepatic lipaseLIPCrs153208515Hepatic lipaseLIPCrs180058815Hepatic lipaseLIPCrs207089515Hepatic lipaseLIPCrs477504115HMG-CoA ReductaseHMGCRrs38466625Lipoprotein lipaseLPLrs3288Polypeptide N-acetylgalactosaminyltransferase 2GALNT2rs21443001Polypeptide N-acetylgalactosaminyltransferase 2GALNT2rs48469141Potassium channel tetramerization domain containing 10KCTD10rs233810412WW Domain Containing OxidoreductaseWWOXrs254886116

2.4. Genotyping {#s0030}
---------------

Genotyping was performed on a MassARRAY platform (Sequenom Inc., San Diego, CA, USA) with iPLEX Gold chemistry. Validation, concordance analysis and quality control were conducted by the facility according to their protocols.

2.5. Statistical analyses {#s0035}
-------------------------

Two-sided t tests were used to compare the distribution of genetic risk scores in populations. To reveal the association between genetic risk, serum HDL-C level and ethnicity several statistical models were used ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}).Table 2Distribution of study populations by wGRS quintiles.Table 2**Hungarian general population (%)Hungarian Roma population (%)*****p-value*****1**st **quintile of wGRS (0.15--≤0.30)**1.830.510.025**2**nd **quintile of wGRS (0.31--≤0.45)**17.1810.45\<0.001**3**rd **quintile of wGRS (0.46--\<0.59)**48.3849.140.756**4**th **quintile of wGRS (0.6--≤ 0.74)**3034.760.037**5**th **quintile of wGRS (0.75--0.88)**2.615.140.004Table 3Output of multiple regression models using unweighted and weighted genetic risk scores as dependent variable and ethnicity, age and sex as independent variables.Table 3Dependent variable: GRSR Square=0.009**Independent variablesCoefficient*****p-value****β*****Ethnicity (Roma vs. General)**0.667\<0.0010.092**Sex women vs. men)**0.1060.4770.016**Age**−0.00030.068−0.001*β*: relative strength of predictorsDependent variable: wGRSR Square=0.017**Independent variablesCoefficient*****p-value****β*****Ethnicity (Roma vs. General)**0.029\<0.0010.125**Sex (women vs. men)**−0.0010.774−0.006**Age**−0.00020.202−0.028*β*: relative strength of predictors[^1]Table 4Proportion of subjects with reduced plasma HDL-C level in the General and Roma populations according to wGRS quintiles.Table 4**1st quintile of wGRS (0.15--≤0.30)2nd quintile of wGRS (0.31--≤0.45)3rd quintile of wGRS 0.46--\<0.59)4th quintile of wGRS5th quintile of wGRS (0.75--0.88)*****p-values*****for trend(0.6--≤0.74)General (Men; Women)*N*=26 (8;18)*N*=241 (115;126)*N*=681 (320;361)*N*=417 (200;217)*N*=36 (21;15)**Average HDL-C level (mmol/l)1.561.471.411.381.330.021Reduced plasma HDL-C (%)11.5423.7727.828.531.430.083**Roma (Men; Women)*N*=3 (1;2)*N*=61 (28;33)*N*=287 (112;175)*N*=203 (76;127)*N*=30 (11;19)**Average HDL-C level (mmol/l)1.261.241.231.21.090.076Reduced plasma HDL-C (%)33.3344.2649.8352.2256.670.054Table 5Association of GRSs with plasma HDL-C[a](#tbl5fna){ref-type="table-fn"} level by study groups.Table 5**Hungarian GeneralHungarian Roma*β* (95% CI)*****p-value******β* (95% CI)*****p-value*****GRSModel I**−0.01 (−0.018 to −0.003)0.004−0.013 (−0.023 to −0.003)0.011**Model II**−0.011 (−0.018 to −0.004)0.003−0.013 (−0.023 to −0.003)0.009**wGRSModel III**−0.243 (−0.466 to −0.020)0.033−0.318 (−0.633 to −0.002)0.049**Model IV**−0.205 (−0.420 to 0.101)0.062−0.336 (−0.651 to −0.21)0.036[^2][^3][^4]Table 6The association of HDL-C level with genetic risk scores adjusted by ethnicity, sex and age.Table 6Dependent variable: reduced plasma HDL-C levelR Square=0.046**Independent variablesOR (95% CI)*****p-value*****Genetic constitution defined by GRS**1.07 (1.04--3.31)\<0.001**Ethnicity (Roma vs. General)**2.70 (2.19--3.31)\<0.001**Sex (women vs. men)**0.99 (0.81--1.20)0.942**Age**1.00 (0.99--1.01)0.393Dependent variable: reduced plasma HDL-C levelR Square=0.042**Independent variablesOR (95% CI)*****p-value*****Genetic constitution defined by wGRS**3.89 (1.56--9.69)0.004**Ethnicity (Roma vs. General)**2.69 (2.19--3.31)\<0.001**Sex (women vs. men)**1.00 (0.83--1.21)0.993**Age**1.00 (0.99--1.01)0.353[^5]

Ethical approval {#s0040}
================

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

This study was approved by the Ethical Committee of the University of Debrecen, Medical Health Sciences Centre (Reference no. 2462-2006) and by the Ethical Committee of the Hungarian Scientific Council on Health (Reference nos. NKFP/1/0003/2005 and 8907-O/2011-EKU).

This article does not contain any studies with animals performed by any of the authors.
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Transparency data document associated with this article can be found in the online version at doi: [10.1016/j.atherosclerosis.2017.05.028](http://dx.doi.org/10.1016/j.atherosclerosis.2017.05.028){#ir0004}.

Supplementary data associated with this article can be found in the online version at doi: [10.1016/j.atherosclerosis.2017.05.028](http://dx.doi.org/10.1016/j.atherosclerosis.2017.05.028){#ir0005}.

[^1]: Multivariate regression analysis using age, sex as covariates did not change the inference neither for the GRS nor for wGRS.

[^2]: The association of GRS and wGRS with plasma HDL-C level were evaluated under unadjusted regression models (Model I and III) and under regression models adjusted for age and sex (Model II and IV) separately in Roma and general subjects. In all models the HDL-C was the dependent variable, the GRS/wGRS were the independent variables.

[^3]: 95% CI: 95% confidence interval

[^4]: HDL-C values were non-normally distributed and were transformed using a two-step approach suggested by Templeton [@bib4].

[^5]: OR: odds ratio.
